Omega Alpha SPAC, formed in 2020 and based in Boston, Massachusetts, operated as a blank check company. Its primary objective was to complete a business combination, such as a merger, share exchange, or asset acquisition, with a target company. The firm specifically focused on seeking opportunities within the healthcare or biotechnology sectors in developed markets like North America and Europe. Ultimately, the company’s board concluded that it would be unable to finalize an initial business combination within the stipulated period. As a result, Omega Alpha SPAC proceeded with an early liquidation, and its public shares were redeemed on December 28, 2022.